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Dosimetric evaluation of arc-based modulated electron radiation therapy A. Joosten 1 , D. Henzen 1 , W. Volken 1 , D. Frei 1 , K. Lössl 1 , P. Manser 1 , M.K. Fix 1 1 Inselspital Bern University, Division of Medical Radiation Physics and Department of Radiation Oncology, Bern, Switzerland Purpose/Objective: To perform a dosimetric evaluation of arc-based modulated electron radiation therapy (arc-MERT) using a direct aperture optimization (DAO) algorithm. Materials and Methods: An arc-MERT plan was mimicked by setting a series of field ports with small angle increments (between 6° and 15° depending on the case). When possible, a single isocenter was used for the field set-up; this was not always possible due to the short source-to-skin distance (~70cm) used for MERT planning using the photon MLC for beam collimation. For each field port, beamlet dose distributions were generated for several different electron beam energies. A treatment plan is created by selecting and optimizing the shape and the weight of a certain number of initial apertures per beam energy and per field. Thus, different combinations of apertures can be investigated with the available field ports and beam energies. This approach was applied for two clinically motivated situations: a head and neck and a breast case. For the head and neck case, 13 field ports spanning a 140° arc were set up using multiple isocenters. For the breast case, 6 field ports spanning a 30° arc were set up using a single isocenter. For both cases, many plans were generated using different combinations of apertures (between 10 and 90 apertures per plan). The dose homogeneity to the PTV as well as the doses to organs at risk (OAR) were determined and compared to photon plans. Results: Using arc-MERT, it is possible to achieve a high dose homogeneity to the PTV (V95%-V107% > 95%), which is similar to the photon plan. Good treatment plans can already be achieved using between 30 to 50 apertures and more than one electron beam energy. For the head and neck case, the organs at risk sparing was similar to the original VMAT plan, while the low dose bath could be substantially reduced with arc-MERT (V10% = 554 cc versus 1150 cc for VMAT). For the breast case, the high dose homogeneity to the PTV achieved with arc-MERT came at the cost of high ipsilateral lung doses (mean dose 20 Gy, V30Gy = 34%). If the CTV had to be adequately covered instead of the PTV (defined for tangential photon plans), the doses to the ipsilateral lung could be substantially reduced (mean dose 7.3 Gy, V30Gy=1%). Conclusions: arc-MERT offers the potential to achieve high dose homogeneity to the PTV similar to photon plans and depending on the case also similar OAR sparing while reducing the low dose bath. More work is required to define which sites would most benefit from arc-MERT. This work is supported by the Swiss Cancer Research grant KFS-3279-08-2013.
